Biogenosis SA
Biogenosis reported total assets of €16.4m at the end of the 2023 financial year (annual accounts filed with the NBB on 10 Mar 2025).
The score of Biogenosis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity +77 % Total assets +111 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biogenosis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2023filed on 10 Mar 2025
- Year ended 31 Dec 2022filed on 13 Nov 2023
- Year ended 31 Dec 2021filed on 19 Sep 2022
- Year ended 31 Dec 2020filed on 30 Sep 2021
- Year ended 31 Dec 2019filed on 07 Oct 2020
Biogenosis's financial analysis
Management and control of Biogenosis
Biogenosis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0500.705.585
- VAT number
- BE0500705585
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 09 Nov 2012
- Registered office
- 4000 Liège
- Latest accounts
- 2023 · filed on 10 Mar 2025
Biogenosis (SA) has been based in Liège since 2012, active in: —. For 2023, it reports a net profit of 79,471 € and equity of €13.0m; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biogenosis
Companies in the same business, of comparable size and area, outside its group.
- Quaestor imec.xpand II Other activities auxiliary to financial services, except insurance and pension funding Roeselare · balance sheet €11.4m
- Actobio Laboratories Belgium Activities of holding companies Nazareth-De Pinte · balance sheet €9.69m
- Theodorus IV Activities of holding companies Anderlecht · balance sheet €11.2m
- Arteva Capital Activities of holding companies Waasmunster · balance sheet €25.3m
- Bioqube Factory Fund II Privak Activities of holding companies Brussels · balance sheet €12.1m
- Capricorn SCF Activities of holding companies Leuven · balance sheet €23.6m
- Compagnie Financiere des Minimes Activities of holding companies Saint-Gilles · balance sheet €9.81m
- Odin Ventures Activities of holding companies Hasselt · balance sheet €9.40m
Frequently asked questions about Biogenosis
What is the revenue of Biogenosis?
Biogenosis files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of Biogenosis?
In Belgium, the VAT number is the company number prefixed with BE: BE0500705585 for Biogenosis, if the company is VAT-registered. Its company number (CBE) is 0500.705.585.
Where is the registered office of Biogenosis?
According to the CBE register, the registered office of Biogenosis is in 4000 Liège.
What is the equity of Biogenosis?
At the close of the 2023 financial year, the equity of Biogenosis amounts to 13,004,751 €, a solvency of 79.3% of total assets.
Who manages Biogenosis?
The register lists 3 active mandates at Biogenosis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biogenosis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →